US OptionsDetailed Quotes
RIGL241220C11000
- 3.40
- 0.000.00%
15min DelayClose Dec 3 16:00 ET
0.00High0.00Low
3.40Open3.40Pre Close0 Volume2 Open Interest11.00Strike Price0.00Turnover354.43%IV-46.77%PremiumDec 20, 2024Expiry Date16.05Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9411Delta0.0057Gamma1.61Leverage Ratio-0.0724Theta0.0040Rho1.52Eff Leverage0.0068Vega
Rigel Pharmaceuticals Stock Discussion
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
25.+
Go, Go, Go!!!
No comment yet